The latest news and press releases about ValGenesis and our VLMS platform.
November 16, 2021 | ValGenesis, Inc., a market leader in enterprise Validation Lifecycle Management Systems (VLMS), is proud to announce its new corporate brand identity and redesigned logo. The new design system better reflects the company’s values and positions it for new levels of growth.
ValGenesis, Inc., a market leader in enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Steve Reynolds as Chief Revenue Officer. Steve will oversee revenue growth through his leadership of the sales team as well as development of new growth strategies.
ValGenesis appoints Mike Hicks as Chief Technology Officer. "I am incredibly excited to join a clear market leader and to be part of the innovative leadership team at ValGenesis.
ValGenesis, Inc., announced the appointment of Bo Olsen as Head of European Operations. Bo will be in charge of developing business opportunities and expanding ValGenesis's operation in the European region.
ValGenesis, Inc., a market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Kevin Potts as Vice President of Marketing, effective August 1, 2021.
One of the top ten global pharmaceutical companies selected ValGenesis’ eLog solution to meet its global needs for the digitization of logbooks.
ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Systems (VLMS), today announced the appointment of Kevin O’Donnell as Chief Financial Officer, effective August 2, 2021.
A top Italian life sciences company has chosen to implement ValGenesis’ 100% paperless Validation Lifecycle Management System (VLMS) to manage its corporate validation lifecycle process.
Digitization of backend processes and workflow automation is a rapidly emerging area of growth for healthcare and life sciences companies. As a market leader, ValGenesis offers a fit-for-purpose platform for validation lifecycle management, resulting in significant cost and time efficiencies for global, compliance focused organizations.
A U.S. based cell therapies company has selected ValGenesis VLMS – the industry’s most trusted electronic validation lifecycle management system – to digitize multiple corporate validation lifecycle processes across the organization.
